Search Results
MBCC 2017: Multiple PARP inhibitors show promise in breast cancer treatment
Future Role of PARP Inhibition in BRCA+ Breast Cancer
New drugs on the block - PARP inhibitors
MBCC 2017: It’s too early to give up on immunotherapy for breast cancer
Differences Among PARP Inhibitors in Ovarian Cancer
PARP Inhibitors in Other Subtypes of Breast Cancer
Dr. Litton on the Impact of PARP Inhibitors in Breast Cancer
Ovarian Cancer: Talking to Patients About PARP Inhibitors
Role for PARP Inhibitors as Maintenance Therapy
Ovarian Cancer: How PARP Inhibitors Work
PARP Inhibitors for Ovarian Cancer: Use of Olaparib
Understanding the Side Effects of PARP Inhibitors
